1. Moshynska OV, Saxena A. Clonal relationship between Hashimoto thyroiditis and thyroid lymphoma. J Clin Pathol. 2008. 61:438–444.
2. Tamimi DM. The association between chronic lymphocytic thyroiditis and thyroid tumors. Int J Surg Pathol. 2002. 10:141–146.
3. Yeh HC, Futterweit W, Gilbert P. Micronodulation: ultrasonographic sign of Hashimoto thyroiditis. J Ultrasound Med. 1996. 15:813–819.
4. Toldy E, Lócsei Z, Kalmár I, Varga L, Kovács LG. [Diagnostic value of thyroid antibodies]. Orv Hetil. 1996. 137:2075–2080.
5. Pedersen OM, Aardal NP, Larssen TB, Varhaug JE, Myking O, Vik-Mo H. The value of ultrasonography in predicting autoimmune thyroid disease. Thyroid. 2000. 10:251–259.
6. Kurukahvecioglu O, Taneri F, Yüksel O, Aydin A, Tezel E, Onuk E. Total thyroidectomy for the treatment of Hashimoto's thyroiditis coexisting with papillary thyroid carcinoma. Adv Ther. 2007. 24:510–516.
7. Erdogan M, Erdem N, Cetinkalp S, Ozgen AG, Saygılı F, Yilmaz C, et al. Demographic, clinical, laboratory, ultrasonographic, and cytological features of patients with Hashimoto's thyroiditis: results of a university hospital of 769 patients in Turkey. Endocrine. 2009. 36:486–490.
8. Takashima S, Matsuzuka F, Nagareda T, Tomiyama N, Kozuka T. Thyroid nodules associated with Hashimoto thyroiditis: assessment with US. Radiology. 1992. 185:125–130.
9. Ohmori N, Miyakawa M, Ohmori K, Takano K. Ultrasonographic findings of papillary thyroid carcinoma with Hashimoto's thyroiditis. Intern Med. 2007. 46:547–550.
10. Kim DW, Eun CK, In HS, Kim MH, Jung SJ, Bae SK. Sonographic differentiation of asymptomatic diffuse thyroid disease from normal thyroid: a prospective study. AJNR Am J Neuroradiol. 2010. 31:1956–1960.
11. Liu Y. Clinical significance of thyroid uptake on F18-fluorodeoxyglucose positron emission tomography. Ann Nucl Med. 2009. 23:17–23.
12. Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med. 1994. 35:1647–1649.
13. Keyes JW Jr, Harkness BA, Greven KM, Williams DW 3rd, Watson NE Jr, McGuirt WF. Salivary gland tumors: pretherapy evaluation with PET. Radiology. 1994. 192:99–102.
14. Braams JW, Pruim J, Freling NJ, Nikkels PG, Roodenburg JL, Boering G, et al. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med. 1995. 36:211–216.
15. Kim HK, Yoon JH, Kim SJ, Kang HC. Clinical meaning of diffuse 18F-FDG PET thyroid uptake. Korean J Med. 2011. 81:595–601.
16. Kang KW, Kim SK, Kang HS, Lee ES, Sim JS, Lee IG, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab. 2003. 88:4100–4104.
17. Yasuda S, Shohtsu A, Ide M, Takagi S, Takahashi W, Suzuki Y, et al. Chronic thyroiditis: diffuse uptake of FDG at PET. Radiology. 1998. 207:775–778.
18. Silverman PM, Newman GE, Korobkin M, Workman JB, Moore AV, Coleman RE. Computed tomography in the evaluation of thyroid disease. AJR Am J Roentgenol. 1984. 142:897–902.
19. Iida Y, Konishi J, Harioka T, Misaki T, Endo K, Torizuka K. Thyroid CT number and its relationship to iodine concentration. Radiology. 1983. 147:793–795.
20. Radecki PD, Arger PH, Arenson RL, Jennings AS, Coleman BG, Mintz MC, et al. Thyroid imaging: comparison of high-resolution real-time ultrasound and computed tomography. Radiology. 1984. 153:145–147.